Allogeneic transplantation using mini-conditioning for treatment of stage IV breast cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Docetaxel; Doxorubicin; Filgrastim; Fludarabine; Sargramostim
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Jun 2010 Biomarkers information updated
- 03 May 2010 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 23 Feb 2010 Planned end date added to 1 Jan 2001 as reported by ClinicalTrials.gov.